Article

Nidek introduces phacoemulsification system, acrylic IOL

Lisbon, Portugal - Nidek Co., Gamagori, Japan, introduces its CV-7000 Phacoemulsification System and its Nex-Acri IOL.

Lisbon, Portugal - Nidek Co., Gamagori, Japan, introduces its CV-7000 Phacoemulsification System and its Nex-Acri IOL.

The CV-7000 Phacoemulsification System delivers a new standard in cataract surgery, providing a high-repetitive pulse mode for excellent operability and reduced thermal/heat generation. Pro-Pedal Mode achieves a high anterior chamber stability providing for greater visualization and fast surgery times, the company said.

The system also delivers improved peristaltic technology, which provides for a faster (up to 40%) set-up time compared with conventional phaco systems, according to the company. The system’s newly designed, reusable titanium handpiece delivers 40 kHz of ultrasound for phacoemulsification. The phaco system also recently received the CE Mark in Europe.

The Nex-Acri IOL is a hydrophobic acrylic foldable IOL.

For more information about the phacoemulsification system and the IOL, visit Booth #227.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
Sheng Lim, MD, FRCOphth, discusses the CONCEPT study, which compared standalone cataract surgery to cataract surgery with ECP, at the 2025 ASCRS Annual Meeting.
(Image credit: Ophthalmology Times) ASCRS 2025: Steven J. Dell, MD, reports 24-month outcomes for shape-changing IOL
© 2025 MJH Life Sciences

All rights reserved.